Literature DB >> 26517968

A critical role for alpha-synuclein in development and function of T lymphocytes.

Afshin Shameli1, Wenbin Xiao1, Yan Zheng1, Susan Shyu1, John Sumodi1, Howard J Meyerson1, Clifford V Harding1, Robert W Maitta2.   

Abstract

Alpha-synuclein is highly expressed in the central nervous system and plays an important role in pathogenesis of neurodegenerative disorders such as Parkinson's disease and Lewy body dementia. Previous studies have demonstrated the expression of α-synuclein in hematopoietic elements and peripheral blood mononuclear cells, although its roles in hematopoiesis and adaptive immunity are not studied. Using an α-synuclein knock out (KO) mouse model, we have recently shown that α-synuclein deficiency is associated with a mild defect in late stages of hematopoiesis. More importantly, we demonstrated a marked defect in B lymphocyte development and IgG, but not IgM production in these mice. Here we show a marked defect in development of T lymphocytes in α-synuclein KO mice demonstrated by a significant increase in the number of CD4 and CD8 double negative thymocytes and significant decreases in the number of CD4 single positive and CD8 single positive T cells. This resulted in markedly reduced peripheral T lymphocytes. Interestingly, splenic CD4(+) and CD8(+) T cells that developed in α-synuclein KO mice had a hyperactivated state with higher expression of early activation markers and increased IL-2 production. Moreover, splenic CD4(+) T cells from α-synuclein KO mice produced lower levels of IL-4 upon antigenic stimulation suggesting a defective Th2 differentiation. Our data demonstrate an important role for α-synuclein in development of T lymphocytes and regulation of their phenotype and function.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CD4; CD8; Lymphopoiesis; T cells; Treg; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 26517968      PMCID: PMC4688145          DOI: 10.1016/j.imbio.2015.10.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  40 in total

1.  Alterations of T-lymphocyte populations in Parkinson disease.

Authors:  Yasuhiko Baba; Ataru Kuroiwa; Ryan J Uitti; Zbigniew K Wszolek; Tatsuo Yamada
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

Review 2.  Immunoglobulin class switching.

Authors:  J Stavnezer
Journal:  Curr Opin Immunol       Date:  1996-04       Impact factor: 7.486

3.  Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.

Authors:  X Tao; C Grant; S Constant; K Bottomly
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

Review 4.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

Authors:  S L Constant; K Bottomly
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

Authors:  M C Irizarry; W Growdon; T Gomez-Isla; K Newell; J M George; D F Clayton; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1998-04       Impact factor: 3.685

6.  NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation.

Authors:  M Hashimoto; M Yoshimoto; A Sisk; L J Hsu; M Sundsmo; A Kittel; T Saitoh; A Miller; E Masliah
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

7.  The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system.

Authors:  A Iwai; E Masliah; M Yoshimoto; N Ge; L Flanagan; H A de Silva; A Kittel; T Saitoh
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

8.  Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage.

Authors:  Masaaki Nakai; Masayo Fujita; Masaaki Waragai; Shuei Sugama; Jianshe Wei; Hiroyasu Akatsu; Chiaki Ohtaka-Maruyama; Haruo Okado; Makoto Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  2007-04-25       Impact factor: 3.575

Review 9.  The synuclein family.

Authors:  C Lavedan
Journal:  Genome Res       Date:  1998-09       Impact factor: 9.043

10.  Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment.

Authors:  Hidehiro Yamane; Jinfang Zhu; William E Paul
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

View more
  33 in total

Review 1.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

2.  Ultrastructural changes in peripheral blood leukocytes in α-synuclein knockout mice.

Authors:  Hammad Tashkandi; Afshin Shameli; Clifford V Harding; Robert W Maitta
Journal:  Blood Cells Mol Dis       Date:  2018-09-01       Impact factor: 3.039

3.  α-Synuclein concentration increases over time in plasma supernatant of single donor platelets.

Authors:  Catherine M Stefaniuk; Hong Hong; Clifford V Harding; Robert W Maitta
Journal:  Eur J Haematol       Date:  2018-07-28       Impact factor: 2.997

Review 4.  α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Authors:  Kaie Rosborough; Neha Patel; Lorraine V Kalia
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

5.  Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease.

Authors:  Jonas Folke; Emil Bergholt; Bente Pakkenberg; Susana Aznar; Tomasz Brudek
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

Review 6.  T Lymphocytes in Parkinson's Disease.

Authors:  Elena Contaldi; Luca Magistrelli; Cristoforo Comi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

7.  Initial assessment of α-synuclein structure in platelets.

Authors:  Catherine M Stefaniuk; June Schlegelmilch; Howard J Meyerson; Clifford V Harding; Robert W Maitta
Journal:  J Thromb Thrombolysis       Date:  2021-11-19       Impact factor: 5.221

8.  The localization of α-synuclein in the process of differentiation of human erythroid cells.

Authors:  Katsuya Araki; Kotomi Sugawara; Eri H Hayakawa; Kumi Ubukawa; Isuzu Kobayashi; Hideki Wakui; Naoto Takahashi; Kenichi Sawada; Hideki Mochizuki; Wataru Nunomura
Journal:  Int J Hematol       Date:  2018-04-24       Impact factor: 2.490

Review 9.  Emerging therapies in Parkinson disease - repurposed drugs and new approaches.

Authors:  Ahmad Elkouzi; Vinata Vedam-Mai; Robert S Eisinger; Michael S Okun
Journal:  Nat Rev Neurol       Date:  2019-04       Impact factor: 42.937

Review 10.  Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.

Authors:  Elizabeth M Kline; Madelyn C Houser; Mary K Herrick; Philip Seibler; Christine Klein; Andrew West; Malú G Tansey
Journal:  Mov Disord       Date:  2020-12-14       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.